BLFS FY 2024 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

FY 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$82M+8.4% YoY

Gross Profit

$54M65.3% margin

Operating Income

-$7M-8.7% margin

Net Income

-$20M-24.5% margin

EPS (Diluted)

$-0.44

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$5M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$399M

Total Liabilities

$51M

Stockholders' Equity

$349M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$76M	+8.4%
Gross Profit	$54M	$47M	+14.8%
Operating Income	-$7M	-$23M	+69.6%
Net Income	-$20M	-$66M	+69.6%